These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1328992)

  • 1. Vaccine pamphlet supplement released.
    Longenecker RE
    Pa Med; 1992 Jul; 95(7):10. PubMed ID: 1328992
    [No Abstract]   [Full Text] [Related]  

  • 2. ACIP releases recommendations on the combined DTP and Hib vaccine. Advisory Committee on Immunization Practices.
    Am Fam Physician; 1994 Feb; 49(2):501, 505. PubMed ID: 8304266
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphtheria, tetanus, and pertussis.
    Nurse Pract; 1996 Jul; 21(7):94-7. PubMed ID: 8823790
    [No Abstract]   [Full Text] [Related]  

  • 4. The recommended childhood immunization schedule of the United States. Committee on Infectious Diseases, American Academy of Pediatrics and Center for Disease Control.
    Hall CB
    Pediatrics; 1995 Jan; 95(1):135-7. PubMed ID: 7770292
    [No Abstract]   [Full Text] [Related]  

  • 5. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphtheria, tetanus, and pertussis: Guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1981 Dec; 95(6):723-8. PubMed ID: 6272621
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphtheria, tetanus and pertussis vaccine.
    Nurs Times; 2004 Nov 23-29; 100(47):35. PubMed ID: 15626045
    [No Abstract]   [Full Text] [Related]  

  • 8. U.S. clinical trials with Takeda acellular pertussis vaccine.
    Stout MG
    Tokai J Exp Clin Med; 1988; 13 Suppl():21-8. PubMed ID: 2908521
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunization crisis in New York.
    Farnsworth PB
    N Y State J Med; 1993 Mar; 93(3):201-2. PubMed ID: 8384351
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approval of a fourth acellular pertussis vaccine for use among infants and young children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(43):934-6. PubMed ID: 9822368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised diphtheria, tetanus, and pertussis (DTP/DTaP/DT) vaccine information materials--CDC. Notice.
    Fed Regist; 1998 Jan; 63(6):1730-3. PubMed ID: 10177063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following immunization.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 34(3):43-7. PubMed ID: 2981396
    [No Abstract]   [Full Text] [Related]  

  • 14. Food and Drug Administration approval of use of Haemophilus influenzae type b conjugate vaccine reconstituted with diphtheria-tetanus-pertussis vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Dec; 42(49):964-5. PubMed ID: 8246862
    [No Abstract]   [Full Text] [Related]  

  • 15. Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):676-7. PubMed ID: 8778580
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approval of a second acellular pertussis vaccine for use among infants and young children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(5):110-1. PubMed ID: 9045038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current epidemiology of pertussis in the United States.
    Hutchins SS; Cochi SL; Brink EW; Patriarca PA; Wassilak SG; Rovira EZ; Hinman AR
    Tokai J Exp Clin Med; 1988; 13 Suppl():103-9. PubMed ID: 2856218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age.
    Rothstein EP; Kamiya H; Nii R; Matsuda T; Bernstein HH; Long SS; Hosbach PH; Meschievitz CK
    Pediatrics; 1996 Feb; 97(2):236-42. PubMed ID: 8584384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(45):993-5. PubMed ID: 9005308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.